ERBB2 and metastatic neoplasm: Evaluation in a Western population, also with localized and metastatic disease but without the use of adjuvant treatment, detected a prognostic influence of HER2 and HER3 expression by univariate analysis; however, this was not reproduced by multivariate analysis [10, 17].